Luteolin inhibits the TGF-β signaling pathway to overcome bortezomib resistance in multiple myeloma.
Li Z, Wang H, Wang Y, Ma Z, Hu L, Luo S, Gong Y, Zhu L, Gong H, Xiang R, Zhu Y, Xie Y, Yang C, Peng H, Liu J, Xiao X.
Li Z, et al. Among authors: wang h, wang y.
Cancer Lett. 2023 Feb 1;554:216019. doi: 10.1016/j.canlet.2022.216019. Epub 2022 Nov 26.
Cancer Lett. 2023.
PMID: 36442773